Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals in June, 2018 for $232,276.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA224450-01A1 | Phase I | 232,276 | June 4, 2018 | |||||||
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals in June, 2005 for $99,931.0 USD from the U.S. Department of Defense. | SBIR | N00014-05-M-0121 | Phase I | 99,931 | June 6, 2005 | |||||||
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals for $144,103.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA180403-01A1 | Phase I | 144,103 | ||||||||
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals for $130,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM084517-01 | Phase I | 130,000 | ||||||||
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals for $119,992.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI063790-01 | Phase I | 119,992 | ||||||||
A SBIR Phase I contract was awarded to Mpex Pharmaceuticals for $265,985.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI058410-01 | Phase I | 265,985 |